annual EBITDA:
-$175.87M-$148.93M(-552.77%)Summary
- As of today (September 18, 2025), CDTX annual EBITDA is -$175.87 million, with the most recent change of -$148.93 million (-552.77%) on December 31, 2024.
- During the last 3 years, CDTX annual EBITDA has fallen by -$133.61 million (-316.21%).
- CDTX annual EBITDA is now -16154.07% below its all-time high of -$1.08 million, reached on December 31, 2013.
Performance
CDTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$27.36M-$2.14M(-8.47%)Summary
- As of today (September 18, 2025), CDTX quarterly EBITDA is -$27.36 million, with the most recent change of -$2.14 million (-8.47%) on June 30, 2025.
- Over the past year, CDTX quarterly EBITDA has dropped by -$16.31 million (-147.71%).
- CDTX quarterly EBITDA is now -282.87% below its all-time high of $14.96 million, reached on September 30, 2022.
Performance
CDTX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$124.03M-$16.31M(-15.14%)Summary
- As of today (September 18, 2025), CDTX TTM EBITDA is -$124.03 million, with the most recent change of -$16.31 million (-15.14%) on June 30, 2025.
- Over the past year, CDTX TTM EBITDA has dropped by -$91.39 million (-280.03%).
- CDTX TTM EBITDA is now -22088.37% below its all-time high of -$559.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CDTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -552.8% | -147.7% | -280.0% |
| 3 y3 years | -316.2% | -108.6% | -89.1% |
| 5 y5 years | -321.5% | -50.7% | -184.3% |
CDTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -552.8% | at low | -282.9% | +49.5% | -1976.6% | at low |
| 5 y | 5-year | -552.8% | at low | -282.9% | +49.5% | -1976.6% | at low |
| alltime | all time | <-9999.0% | at low | -282.9% | +49.5% | <-9999.0% | at low |
CDTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$27.36M(+8.5%) | -$124.03M(+15.1%) |
| Mar 2025 | - | -$25.22M(-53.4%) | -$107.72M(+18.4%) |
| Dec 2024 | -$175.87M(+552.8%) | -$54.12M(+212.3%) | -$90.99M(+99.9%) |
| Sep 2024 | - | -$17.33M(+56.9%) | -$45.52M(+39.5%) |
| Jun 2024 | - | -$11.04M(+30.1%) | -$32.64M(+15.3%) |
| Mar 2024 | - | -$8.49M(-2.0%) | -$28.32M(+66.4%) |
| Dec 2023 | -$26.94M(-19.2%) | -$8.66M(+94.8%) | -$17.02M(-32.9%) |
| Sep 2023 | - | -$4.45M(-33.9%) | -$25.38M(+324.9%) |
| Jun 2023 | - | -$6.72M(-339.0%) | -$5.97M(-51.7%) |
| Mar 2023 | - | $2.81M(-116.5%) | -$12.36M(-62.7%) |
| Dec 2022 | -$33.36M(-21.1%) | -$17.02M(-213.8%) | -$33.14M(+0.8%) |
| Sep 2022 | - | $14.96M(-214.1%) | -$32.89M(-49.9%) |
| Jun 2022 | - | -$13.11M(-27.0%) | -$65.59M(+58.3%) |
| Mar 2022 | - | -$17.96M(+7.1%) | -$41.44M(+0.0%) |
| Dec 2021 | -$42.26M(-40.3%) | -$16.77M(-5.5%) | -$41.43M(-8.6%) |
| Sep 2021 | - | -$17.74M(-260.7%) | -$45.35M(+0.6%) |
| Jun 2021 | - | $11.04M(-161.5%) | -$45.07M(-39.3%) |
| Mar 2021 | - | -$17.96M(-13.2%) | -$74.26M(+4.9%) |
| Dec 2020 | -$70.80M(+69.7%) | -$20.68M(+18.4%) | -$70.80M(+10.3%) |
| Sep 2020 | - | -$17.46M(-3.8%) | -$64.20M(+47.1%) |
| Jun 2020 | - | -$18.15M(+25.2%) | -$43.63M(+10.0%) |
| Mar 2020 | - | -$14.50M(+3.0%) | -$39.68M(-4.2%) |
| Dec 2019 | -$41.72M | -$14.08M(-553.9%) | -$41.42M(-5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $3.10M(-121.9%) | -$43.83M(-28.8%) |
| Jun 2019 | - | -$14.20M(-12.6%) | -$61.52M(-1.3%) |
| Mar 2019 | - | -$16.25M(-1.5%) | -$62.34M(-0.7%) |
| Dec 2018 | -$62.76M(+14.0%) | -$16.49M(+13.0%) | -$62.76M(+5.3%) |
| Sep 2018 | - | -$14.59M(-2.9%) | -$59.59M(+4.3%) |
| Jun 2018 | - | -$15.02M(-9.9%) | -$57.11M(-2.4%) |
| Mar 2018 | - | -$16.67M(+25.2%) | -$58.52M(+6.3%) |
| Dec 2017 | -$55.05M(+15.4%) | -$13.32M(+10.0%) | -$55.05M(-1.5%) |
| Sep 2017 | - | -$12.11M(-26.3%) | -$55.90M(-0.1%) |
| Jun 2017 | - | -$16.43M(+24.5%) | -$55.95M(+9.3%) |
| Mar 2017 | - | -$13.20M(-6.8%) | -$51.20M(+7.3%) |
| Dec 2016 | -$47.70M(+49.8%) | -$14.17M(+16.5%) | -$47.70M(+10.2%) |
| Sep 2016 | - | -$12.16M(+4.2%) | -$43.29M(+7.6%) |
| Jun 2016 | - | -$11.67M(+20.3%) | -$40.24M(+15.2%) |
| Mar 2016 | - | -$9.71M(-0.5%) | -$34.92M(+9.6%) |
| Dec 2015 | -$31.85M(+223.8%) | -$9.76M(+7.1%) | -$31.85M(+19.5%) |
| Sep 2015 | - | -$9.11M(+43.5%) | -$26.66M(+28.2%) |
| Jun 2015 | - | -$6.35M(-4.4%) | -$20.80M(+30.6%) |
| Mar 2015 | - | -$6.64M(+45.7%) | -$15.92M(+61.8%) |
| Dec 2014 | -$9.84M(+809.1%) | -$4.56M(+40.3%) | -$9.84M(+86.4%) |
| Sep 2014 | - | -$3.25M(+121.2%) | -$5.28M(+160.3%) |
| Jun 2014 | - | -$1.47M(+162.8%) | -$2.03M(+262.8%) |
| Mar 2014 | - | -$559.00K | -$559.00K |
| Dec 2013 | -$1.08M | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Cidara Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Cidara Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of CDTX is -$175.87M
What is the all time high annual EBITDA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual EBITDA is -$1.08M
What is Cidara Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, CDTX annual EBITDA has changed by -$148.93M (-552.77%)
What is Cidara Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of CDTX is -$27.36M
What is the all time high quarterly EBITDA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly EBITDA is $14.96M
What is Cidara Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, CDTX quarterly EBITDA has changed by -$16.31M (-147.71%)
What is Cidara Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of CDTX is -$124.03M
What is the all time high TTM EBITDA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM EBITDA is -$559.00K
What is Cidara Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, CDTX TTM EBITDA has changed by -$91.39M (-280.03%)